Surgical Endoscopy

, Volume 32, Issue 3, pp 1353–1359 | Cite as

Type 2 diabetes mellitus outcomes after laparoscopic gastric bypass in patients with BMI <35 kg/m2 using strict remission criteria: early outcomes of a prospective study among Mexicans

  • Omar Espinosa
  • Omar Pineda
  • Hernan G. Maydón
  • Elisa M. Sepúlveda
  • Lizbeth Guilbert
  • Mónica Amado
  • Carlos Zerrweck
Article

Abstract

Background

Mild obesity (BMI 30–34.9 kg/m2) is highly prevalent worldwide and is associated with type 2 diabetes mellitus. The efficacy of bariatric surgery remains unclear, including among Mexicans. The criteria for diabetes remission are inconsistent, as they are based on different thresholds for glycated hemoglobin, with remission rates ranging from 43 to 73%.

Methods

Mildly obese patients with type 2 diabetes mellitus who underwent laparoscopic gastric bypass were prospectively analyzed. The primary objective was to determine the impact of surgery on their metabolic profiles. Demographic, clinical, and biochemical parameters were measured at baseline and at 3, 6, 9, 12, and 18 months. Diabetes remission rate was defined as an HbA1c <5.7%. Complications within 30 days and weight loss (% total weight loss) were also analyzed.

Results

Twenty-three Mexican patients underwent surgery. Of the 19 patients, evaluable at 18 months, nine (47.4%) achieved complete diabetes remission, seven (36.8%) showed partial remission, and three (15.8%) showed improvement. Significant improvements in lipid profile, cardiovascular risk, blood pressure, and every metabolic parameter were observed, beginning at the first month and throughout the study. The final total percentage weight loss was 24.9%. Three patients (13%) experienced complications, but none required reoperation or died.

Conclusion

Laparoscopic gastric bypass is a safe and effective method to improve the metabolic profile of mildly obese Mexican patients with type 2 diabetes mellitus, inducing high remission rates even when the strictest model is used.

Keywords

Bariatric surgery Metabolic surgery Diabetes surgery Diabetes remission Obesity grade 1 Mild obesity Laparoscopic gastric bypass Surgery Mexicans Latinos 

Notes

Compliance with ethical standards

Conflict of interest

Omar Espinosa, Omar Pineda, Hernan G. Maydón, Elisa M. Sepúlveda, Lizbeth Guilbert, Mónica Amado, and Carlos Zerrweck declare that they have no conflicts of interest or financial ties to disclose.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institution and/or national research committee and with 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in this study.

References

  1. 1.
    Dixon JB, Le Roux CW, Rubino F, Zimmet P (2012) Bariatric surgery for type 2 diabetes. Lancet 379:2300–2311CrossRefPubMedGoogle Scholar
  2. 2.
    Ribaric G, Buchwald JN, McGlennon TW (2014) Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis. Obes Surg 24:437–455CrossRefPubMedGoogle Scholar
  3. 3.
    Yip K, Heinberg L, Giegerich V, Schauer PR, Kashyap SR (2012) Equivalent weight loss with marked metabolic benefit observed in a matched cohort with and without type 2 diabetes 12 months following gastric bypass surgery. Obes Surg 22:1723–1729CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Bays HE, Chapman RH, Grandy S, Group SI (2007) The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pract 61:737–747CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Maggard-Gibbons M, Maglione M, Livhits M, Ewing B, Maher AR, Hu J, Li Z, Shekelle PG (2013) Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review. JAMA 309:2250–2261CrossRefPubMedGoogle Scholar
  6. 6.
    American Diabetes A (2012) Standards of medical care in diabetes-2012. Diabetes Care 35(Suppl 1):S11–63Google Scholar
  7. 7.
    Lopez L, Golden SH (2014) A new era in understanding diabetes disparities among U.S. Latinos—all are not equal. Diabetes Care 37:2081–2083CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    de la Cruz-Munoz N, Messiah SE, Arheart KL, Lopez-Mitnik G, Lipshultz SE, Livingstone A (2011) Bariatric surgery significantly decreases the prevalence of type 2 diabetes mellitus and pre-diabetes among morbidly obese multiethnic adults: long-term results. J Am Coll Surg 212:505–511 discussion 512-503 CrossRefPubMedGoogle Scholar
  9. 9.
    (2015) Standards of medical care in diabetes-2015: summary of revisions. Diabetes Care 38 Suppl:S4Google Scholar
  10. 10.
    Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, McLaughlin S, Phillips GL 2nd, Robertson RP, Rubino F, Kahn R, Kirkman MS (2009) How do we define cure of diabetes? Diabetes Care 32:2133–2135CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122(248–256):e245Google Scholar
  12. 12.
    Buchwald H, Varco E (1978) Metabolic surgery. Grune and Stratton, New YorkGoogle Scholar
  13. 13.
    Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, Nanni G, Pomp A, Castagneto M, Ghirlanda G, Rubino F (2012) Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 366:1577–1585CrossRefPubMedGoogle Scholar
  14. 14.
    Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, Aminian A, Pothier CE, Kim ES, Nissen SE, Kashyap SR, Investigators S (2014) Bariatric surgery versus intensive medical therapy for diabetes–3-year outcomes. N Engl J Med 370:2002–2013CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Muller-Stich BP, Senft JD, Warschkow R, Kenngott HG, Billeter AT, Vit G, Helfert S, Diener MK, Fischer L, Buchler MW, Nawroth PP (2015) Surgical versus medical treatment of type 2 diabetes mellitus in nonseverely obese patients: a systematic review and meta-analysis. Ann Surg 261:421–429CrossRefPubMedGoogle Scholar
  16. 16.
    DePaula AL, Macedo AL, Rassi N, Machado CA, Schraibman V, Silva LQ, Halpern A (2008) Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc 22:706–716CrossRefPubMedGoogle Scholar
  17. 17.
    Abbatini F, Capoccia D, Casella G, Coccia F, Leonetti F, Basso N (2012) Type 2 diabetes in obese patients with body mass index of 30–35 kg/m2: sleeve gastrectomy versus medical treatment. Surg Obes Relat Dis 8:20–24CrossRefPubMedGoogle Scholar
  18. 18.
    Lanzarini E, Csendes A, Gutierrez L, Cuevas P, Lembach H, Molina JC, Musleh M, Braghetto I, Papapietro K, Araya V, Lahsen R, Olguin P, Riffo A, Diaz E, Montt D, Marin L (2013) Type 2 diabetes mellitus in patients with mild obesity: preliminary results of surgical treatment. Obes Surg 23:234–240CrossRefPubMedGoogle Scholar
  19. 19.
    Cohen RV, Pinheiro JC, Schiavon CA, Salles JE, Wajchenberg BL, Cummings DE (2012) Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care 35:1420–1428CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Pournaras DJ, Aasheim ET, Sovik TT, Andrews R, Mahon D, Welbourn R, Olbers T, le Roux CW (2012) Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders. Br J Surg 99:100–103CrossRefPubMedGoogle Scholar
  21. 21.
    Mas-Lorenzo A, Benaiges D, Flores-Le-Roux JA, Pedro-Botet J, Ramon JM, Parri A, Villatoro M, Chillaron J, Pera M, Grande L, Goday A, Obemar G (2014) Impact of different criteria on type 2 diabetes remission rate after bariatric surgery. Obes Surg 24:1881–1887CrossRefPubMedGoogle Scholar
  22. 22.
    Blackstone R, Bunt JC, Cortes MC, Sugerman HJ (2012) Type 2 diabetes after gastric bypass: remission in five models using HbA1c, fasting blood glucose, and medication status. Surg Obes Relat Dis 8:548–555CrossRefPubMedGoogle Scholar
  23. 23.
    Hsu CC, Almulaifi A, Chen JC, Ser KH, Chen SC, Hsu KC, Lee YC, Lee WJ (2015) Effect of bariatric surgery vs medical treatment on type 2 diabetes in patients with body mass index lower than 35: five-year outcomes. JAMA Surg 150:1117–1124CrossRefPubMedGoogle Scholar
  24. 24.
    American Diabetes A (2015) Standards of medical care in diabetes-2015 abridged for primary care providers. Clin Diabetes 33:97–111CrossRefGoogle Scholar
  25. 25.
    Ackermann RT, Cheng YJ, Williamson DF, Gregg EW (2011) Identifying adults at high risk for diabetes and cardiovascular disease using hemoglobin A1c National Health and Nutrition Examination Survey 2005–2006. Am J Prev Med 40:11–17CrossRefPubMedGoogle Scholar
  26. 26.
    Cheng YJ, Gregg EW, Geiss LS, Imperatore G, Williams DE, Zhang X, Albright AL, Cowie CC, Klein R, Saaddine JB (2009) Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: implications for diabetes diagnostic thresholds. Diabetes Care 32:2027–2032CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Puzziferri N, Roshek TB 3rd, Mayo HG, Gallagher R, Belle SH, Livingston EH (2014) Long-term follow-up after bariatric surgery: a systematic review. JAMA 312:934–942CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Caiazzo R, Zerrweck C, Verhaeghe R, Hubert T, Arnalsteen L, Pattou F (2009) Gastric bypass and glucose metabolism. Diabetes Metab 35:528–531CrossRefPubMedGoogle Scholar
  29. 29.
    Zerrweck C, Zurita L, Alvarez G, Maydon HG, Sepulveda EM, Campos F, Caviedes A, Guilbert L (2015) Taste and olfactory changes following laparoscopic gastric bypass and sleeve gastrectomy. Obes Surg 11(6):S15–S16CrossRefGoogle Scholar
  30. 30.
    Chakravartty S, Tassinari D, Salerno A, Giorgakis E, Rubino F (2015) What is the mechanism behind weight loss maintenance with gastric bypass? Curr Obes Rep 4:262–268CrossRefPubMedGoogle Scholar
  31. 31.
    Papamargaritis D, Miras AD, le Roux CW (2013) Influence of diabetes surgery on gut hormones and incretins. Nutr Hosp 28(Suppl 2):95–103PubMedGoogle Scholar
  32. 32.
    Rubino F, Shukla A, Pomp A, Moreira M, Ahn SM, Dakin G (2014) Bariatric, metabolic, and diabetes surgery: what’s in a name? Ann Surg 259:117–122CrossRefPubMedGoogle Scholar
  33. 33.
    Maiz C, Alvarado J, Quezada N, Salinas J, Funke R, Boza C (2015) Bariatric surgery in 1119 patients with preoperative body mass index <35 (kg/m2): results at 1 year. Surg Obes Relat Dis 11:1127–1132CrossRefPubMedGoogle Scholar
  34. 34.
    Boza C, Valderas P, Daroch DA, Leon FI, Salinas JP, Barros DA, Funke RA, Crovari FJ (2014) Metabolic surgery: roux-en-Y gastric bypass and variables associated with diabetes remission in patients with BMI <35. Obes Surg 24:1391–1397CrossRefPubMedGoogle Scholar
  35. 35.
    Sudan R, Winegar D, Thomas S, Morton J (2014) Influence of ethnicity on the efficacy and utilization of bariatric surgery in the USA. J Gastrointest Surg 18:130–136CrossRefPubMedGoogle Scholar
  36. 36.
    Coleman KJ, Huang YC, Koebnick C, Reynolds K, Xiang AH, Black MH, Alskaf S (2014) Metabolic syndrome is less likely to resolve in Mexicans and non-Mexican blacks after bariatric surgery. Ann Surg 259:279–285CrossRefPubMedGoogle Scholar
  37. 37.
    Admiraal WM, Celik F, Gerdes VE, Dallal RM, Hoekstra JB, Holleman F (2012) Ethnic differences in weight loss and diabetes remission after bariatric surgery: a meta-analysis. Diabetes Care 35:1951–1958CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Robert M, Ferrand-Gaillard C, Disse E, Espalieu P, Simon C, Laville M, Gouillat C, Thivolet C (2013) Predictive factors of type 2 diabetes remission 1 year after bariatric surgery: impact of surgical techniques. Obes Surg 23:770–775CrossRefPubMedGoogle Scholar
  39. 39.
    Aarts EO, Janssen J, Janssen IM, Berends FJ, Telting D, de Boer H (2013) Preoperative fasting plasma C-peptide level may help to predict diabetes outcome after gastric bypass surgery. Obes Surg 23:867–873CrossRefPubMedGoogle Scholar
  40. 40.
    Jurowich C, Thalheimer A, Hartmann D, Bender G, Seyfried F, Germer CT, Wichelmann C (2012) Improvement of type 2 diabetes mellitus (T2DM) after bariatric surgery–who fails in the early postoperative course? Obes Surg 22:1521–1526CrossRefPubMedGoogle Scholar
  41. 41.
    Lee MH, Lee WJ, Chong K, Chen JC, Ser KH, Lee YC, Chen SC (2015) Predictors of long-term diabetes remission after metabolic surgery. J Gastrointest Surg 19:1015–1021CrossRefPubMedGoogle Scholar
  42. 42.
    Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, Lamonte MJ, Stroup AM, Hunt SC (2007) Long-term mortality after gastric bypass surgery. N Engl J Med 357:753–761CrossRefPubMedGoogle Scholar
  43. 43.
    Hoerger TJ, Zhang P, Segel JE, Kahn HS, Barker LE, Couper S (2010) Cost-effectiveness of bariatric surgery for severely obese adults with diabetes. Diabetes Care 33:1933–1939CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Makary MA, Clark JM, Shore AD, Magnuson TH, Richards T, Bass EB, Dominici F, Weiner JP, Wu AW, Segal JB (2010) Medication utilization and annual health care costs in patients with type 2 diabetes mellitus before and after bariatric surgery. Arch Surg 145:726–731CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.The Obesity Clinic at Hospital General TláhuacMexico CityMexico

Personalised recommendations